“A comparison of the binding affinities and potencies with reported free … progestins relative to the endogenous mineralocorticoid aldosterone, suggest that all progestins except MPA, NET-A … will likely compete with aldosterone for binding to the MR in vivo at doses … hormonal therapy to elicit physiologically significant off-target effects.”